OpinionJune 14, 2022
We Must End Ageism in Cancer Clinical Trials
Older patients are underrepresented in clinical trial research. Here’s how we can change that
Stories by Dany Habr
Dany Habr is senior vice president and chief medical officer at Pfizer Oncology overseeing the oncology portfolio and medical organization. He has co-authored 40 manuscripts and 80 abstracts in the fields of hematology-oncology and health equity and has presented at major medical conferences.